Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-15-000232
Filing Date
2015-02-17
Accepted
2015-02-17 10:20:26
Documents
1
Group Members
DEERFIELD INTERNATIONAL MASTER FUND, L.P.DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD SPECIAL SITUATIONS FUND, L.P.DEERFIELD SPECIAL SITUATIONS INTERNATIONAL MASTER FUND, L.P.

Document Format Files

Seq Description Document Type Size
1 e613322_sc13ga-insmed.htm SC 13G/A 410618
  Complete submission text file 0001193805-15-000232.txt   412285
Mailing Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807
Business Address 10 FINDERNE AVENUE BUILDING 10 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Subject) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-59149 | Film No.: 15618888
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A